top of page
Regulatory Updates
scroll
In the Media
2020
Research Roundup: July 6, 2026
Best of cannabinoid science this week... In people with mental health problems from tuberous sclerosis complex (a disease of many benign tumors), 6 months of CBD improved eating, sleeping, irritability & manic behavior as well as took the number of people with severe behavior problems from 50% to 0% Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCo
6 days ago3 min read
Federal Updates
2021
Research Roundup: July 6, 2026
Best of cannabinoid science this week... In people with mental health problems from tuberous sclerosis complex (a disease of many benign tumors), 6 months of CBD improved eating, sleeping, irritability & manic behavior as well as took the number of people with severe behavior problems from 50% to 0% Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCo
6 days ago3 min read
2020
Research Roundup: July 6, 2026
Best of cannabinoid science this week... In people with mental health problems from tuberous sclerosis complex (a disease of many benign tumors), 6 months of CBD improved eating, sleeping, irritability & manic behavior as well as took the number of people with severe behavior problems from 50% to 0% Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCo
6 days ago3 min read
State Updates
Arizona
Check back soon
Once posts are published, you’ll see them here.
Colorado
Research Roundup: July 6, 2026
Best of cannabinoid science this week... In people with mental health problems from tuberous sclerosis complex (a disease of many benign tumors), 6 months of CBD improved eating, sleeping, irritability & manic behavior as well as took the number of people with severe behavior problems from 50% to 0% Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCo
6 days ago3 min read
Florida
Research Roundup: July 6, 2026
Best of cannabinoid science this week... In people with mental health problems from tuberous sclerosis complex (a disease of many benign tumors), 6 months of CBD improved eating, sleeping, irritability & manic behavior as well as took the number of people with severe behavior problems from 50% to 0% Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCo
6 days ago3 min read
Idaho
Research Roundup: July 6, 2026
Best of cannabinoid science this week... In people with mental health problems from tuberous sclerosis complex (a disease of many benign tumors), 6 months of CBD improved eating, sleeping, irritability & manic behavior as well as took the number of people with severe behavior problems from 50% to 0% Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCo
6 days ago3 min read
Louisiana
Research Roundup: July 6, 2026
Best of cannabinoid science this week... In people with mental health problems from tuberous sclerosis complex (a disease of many benign tumors), 6 months of CBD improved eating, sleeping, irritability & manic behavior as well as took the number of people with severe behavior problems from 50% to 0% Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCo
6 days ago3 min read
Michigan
Research Roundup: July 6, 2026
Best of cannabinoid science this week... In people with mental health problems from tuberous sclerosis complex (a disease of many benign tumors), 6 months of CBD improved eating, sleeping, irritability & manic behavior as well as took the number of people with severe behavior problems from 50% to 0% Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCo
6 days ago3 min read
New Mexico
Research Roundup: July 6, 2026
Best of cannabinoid science this week... In people with mental health problems from tuberous sclerosis complex (a disease of many benign tumors), 6 months of CBD improved eating, sleeping, irritability & manic behavior as well as took the number of people with severe behavior problems from 50% to 0% Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCo
6 days ago3 min read
New York
Research Roundup: July 6, 2026
Best of cannabinoid science this week... In people with mental health problems from tuberous sclerosis complex (a disease of many benign tumors), 6 months of CBD improved eating, sleeping, irritability & manic behavior as well as took the number of people with severe behavior problems from 50% to 0% Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCo
6 days ago3 min read
Wyoming
Research Roundup: July 6, 2026
Best of cannabinoid science this week... In people with mental health problems from tuberous sclerosis complex (a disease of many benign tumors), 6 months of CBD improved eating, sleeping, irritability & manic behavior as well as took the number of people with severe behavior problems from 50% to 0% Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCo
6 days ago3 min read
bottom of page